miR-494 suppresses the progression of breast cancer in vitro by targeting CXCR4 through the Wnt/β-catenin signaling pathway

Oncology Reports

Volumn 34, Issue 1, 2015, Pages 525-531

  Song, LIngqin ^a   Liu, Di ^a   Wang, Baofeng ^a   He, Jianjun ^a   Zhang, Shuqun ^a   Dai, Zhijun ^a   Ma, Xiaobin ^a   Wang, Xijing ^a  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Breast cancer; CXCR4; Epithelial to mesenchymal transition; MicroRNA 494; Wnt catenin

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BETA CATENIN; CHEMOKINE RECEPTOR CXCR4; CYCLIN D1; HERMES ANTIGEN; LYMPHOID ENHANCER FACTOR 1; MESSENGER RNA; MICRORNA; MICRORNA 494; NERVE CELL ADHESION MOLECULE; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN; WNT PROTEIN; 3' UNTRANSLATED REGION; CXCR4 PROTEIN, HUMAN; MIRN494 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ARTICLE; BREAST CANCER; BREAST CANCER CELL LINE; CANCER INHIBITION; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; CXCR4 GENE; DOWN REGULATION; GENE; GENE EXPRESSION; GENE FUNCTION; GENE INTERACTION; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRACELLULAR SIGNALING; MIGRATION INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; UPREGULATION; WNT SIGNALING PATHWAY; BREAST TUMOR; CELL MOTION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MCF 7 CELL LINE; METABOLISM; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IN VITRO TECHNIQUES; MCF-7 CELLS; MICRORNAS; RECEPTORS, CXCR4; WNT SIGNALING PATHWAY;

EID: 84930028736     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2015.3965     Document Type: Article

References (23)

1. Maruani DM, Spiegel TN, Harris EN, Shachter AS, Unger HA, Herrero-González S and Holz MK: Estrogenic regulation of S6K1 expression creates a positive regulatory loop in control of breast cancer cell proliferation. Oncogene 31: 5073-5080, 2012.
2. Malouf GG, Taube JH, Lu Y, Roysarkar T, Panjarian S, Estecio MR, Jelinek J, Yamazaki J, Raynal NJ, Long H, et al: Architecture of epigenetic reprogramming following Twist1-mediated epithelial-mesenchymal transition. Genome Biol 14: R144, 2013.
3. Gomes LR, Terra LF, Sogayar MC and Labriola L: Epithelial-mesenchymal transition: Implications in cancer progression and metastasis. Curr Pharm Biotechnol 12: 1881-1890, 2011.
4. Hu TH, Yao Y, Yu S, Han LL, Wang WJ, Guo H, Tian T, Ruan ZP, Kang XM, Wang J, et al: SDF-1/CXCR4 promotes epithelial-mesenchymal transition and progression of colorectal cancer by activation of the Wnt/β-catenin signaling pathway. Cancer Lett 354: 417-426, 2014.
5. Saxena M, Stephens MA, Pathak H and Rangarajan A: Transcription factors that mediate epithelial-mesenchymal transition lead to multidrug resistance by upregulating ABC transporters. Cell Death Dis 2: e179, 2011.
6. Haga CL and Phinney DG: MicroRNAs in the imprinted DLK1-DIO3 region repress the epithelial-to-mesenchymal transition by targeting the TWIST1 protein signaling network. J Biol Chem 287: 42695-42707, 2012.
7. Hwang HW, Wentzel EA and Mendell JT: A hexanucleotide element directs microRNA nuclear import. Science 315: 97-100, 2007.
8. Li XH, Qu JQ, Yi H, Zhang PF, Yi HM, Wan XX, He QY, Ye X, Yuan L, Zhu JF, et al: Integrated analysis of differential miRNA and mRNA expression profiles in human radioresistant and radiosensitive nasopharyngeal carcinoma cells. PLoS One 9: e87767, 2014.
9. Zhang C, Li C, Li J, Han J, Shang D, Zhang Y, Zhang W, Yao Q, Han L, Xu Y, et al: Identification of miRNA-mediated core gene module for glioma patient prediction by integrating high-throughput miRNA, mRNA expression and pathway structure. PLoS One 9: e96908, 2014.
10. Romano F, Garancini M, Uggeri F, Degrate L, Nespoli L, Gianotti L, Nespoli A and Uggeri F: Surgical treatment of liver metastases of gastric cancer: State of the art. World J Surg Oncol 10: 157, 2012.
11. 1/S transition in liver tumorigenesis through suppression of mutated in colorectal cancer. Hepatology 59: 202-215, 2014.
12. Olaru AV, Ghiaur G, Yamanaka S, Luvsanjav D, An F, Popescu I, Alexandrescu S, Allen S, Pawlik TM, Torbenson M, et al: MicroRNA down-regulated in human cholangiocarcinoma control cell cycle through multiple targets involved in the G1/S checkpoint. Hepatology 54: 2089-2098, 2011.
13. Liang Z, Yoon Y, Votaw J, Goodman MM, Williams L and Shim H: Silencing of CXCR4 blocks breast cancer metastasis. Cancer Res 65: 967-971, 2005.
14. -ΔΔCT method. Methods 25: 402-408, 2001.
15. Shen PF, Chen XQ, Liao YC, Chen N, Zhou Q, Wei Q, Li X, Wang J and Zeng H: MicroRNA-494-3p targets CXCR4 to suppress the proliferation, invasion, and migration of prostate cancer. Prostate 74: 756-767, 2014.
16. Peng C, Zhou K, An S and Yang J: The effect of CCL19/CCR7 on the proliferation and migration of cell in prostate cancer. Tumour Biol 36: 329-335, 2015.
17. Smith MC, Luker KE, Garbow JR, Prior JL, Jackson E, Piwnica-Worms D and Luker GD: CXCR4 regulates growth of both primary and metastatic breast cancer. Cancer Res 64: 8604-8612, 2004.
18. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL and Weinberg RA: Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121: 335-348, 2005.
19. Wielenga VJ, Smits R, Korinek V, Smit L, Kielman M, Fodde R, Clevers H and Pals ST: Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway. Am J Pathol 154: 515-523, 1999.
20. MacDonald BT, Tamai K and He X: Wnt/beta-catenin signaling: Components, mechanisms, and diseases. Dev Cell 17: 9-26, 2009.
21. Nusse R, Fuerer C, Ching W, Harnish K, Logan C, Zeng A, ten Berge D and Kalani Y: Wnt signaling and stem cell control. Cold Spring Harb Symp Quant Biol 73: 59-66, 2008.
22. Benhaj K, Akcali KC and Ozturk M: Redundant expression of canonical Wnt ligands in human breast cancer cell lines. Oncol Rep 15: 701-707, 2006.
23. Schlange T, Matsuda Y, Lienhard S, Huber A and Hynes NE: Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation. Breast Cancer Res 9: R63, 2007.